LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Начало・Списък с акции・Abbott Laboratories

Search

Abbott Laboratories

Затворен

СекторЗдравеопазване

87.43 -0.3

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

87.27

Максимум

87.63

Ключови измерители
By Trading Economics
Приходи	-699M 1.1B
Продажби	-295M 11B
P/E Средно за сектора	24.625 49.701
EPS	1.15
Дивидентна доходност	2.89
Марж на печалбата	9.647
Служители	122,000
EBITDA	-980M 1.8B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+37.56% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	2.89% 2.39%
Следващи печалби	16.07.2026 г.
Следваща дата на дивидент	14.08.2026 г.
Следваща дата на екс-дивидент	14.07.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-22B 153B
Предишно отваряне	87.73
Предишно затваряне	87.43

Настроения в новините

By Acuity

32%

68%

88 / 345 Класиране в Healthcare

Abbott Laboratories Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.04.2026 г., 15:13 ч. UTC

Печалби

Значими двигатели на пазара

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

16.04.2026 г., 12:23 ч. UTC

Печалби

Значими двигатели на пазара

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

22.01.2026 г., 18:36 ч. UTC

Печалби

Значими двигатели на пазара

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

22.01.2026 г., 13:23 ч. UTC

Печалби

Значими двигатели на пазара

Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms

16.04.2026 г., 20:23 ч. UTC

Печалби

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16.04.2026 г., 16:15 ч. UTC

Печалби

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16.04.2026 г., 14:00 ч. UTC

Пазарно говорене

Печалби

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

16.04.2026 г., 13:59 ч. UTC

Пазарно говорене

Печалби

Abbott Laboratories Has Disappointing Quarter -- Market Talk

16.04.2026 г., 12:05 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

16.04.2026 г., 11:32 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs 1Q Sales $11.16B >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs 1Q Net $1.08B >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs 1Q Adj EPS $1.15 >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

16.04.2026 г., 11:30 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Abbott Labs 1Q EPS 61c >ABT

11.04.2026 г., 00:00 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Big Yachts, Big Bucks -- Barrons.com

23.03.2026 г., 12:50 ч. UTC

Придобивния, сливания и поглъщания

Abbott Completes Acquisition Of Exact Sciences >ABT

20.03.2026 г., 13:01 ч. UTC

Придобивния, сливания и поглъщания

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

20.03.2026 г., 13:00 ч. UTC

Придобивния, сливания и поглъщания

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

28.01.2026 г., 14:48 ч. UTC

Печалби

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

23.01.2026 г., 16:59 ч. UTC

Печалби

Correction to Abbott Stock Drops Article on Jan. 22

22.01.2026 г., 20:42 ч. UTC

Печалби

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22.01.2026 г., 16:19 ч. UTC

Печалби

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22.01.2026 г., 15:22 ч. UTC

Печалби

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

22.01.2026 г., 14:41 ч. UTC

Горещи акции

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

22.01.2026 г., 14:08 ч. UTC

Пазарно говорене

Печалби

Abbott Posts Disappointing 4Q -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Abbott Laboratories Прогноза

Ценова цел

By TipRanks

37.56% нагоре

12-месечна прогноза

Среден 120.24 USD 37.56%

Висок 143 USD

Нисък 92 USD

Според 20 анализатори от Wall Street, предложили 12-месечна ценова цел за Abbott Laboratories през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

20 ratings

16

Купи

4

Задържане

0

Продай

Според 20 анализатори, дали борсови рейтинги на Abbott Laboratories през последните 3 месеца.

Настроение

By Acuity

88 / 345 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Други акции от сектора

LLY

Eli Lilly and Co.

1,066.82

JNJ

Johnson and Johnson

234.57

ABBV

AbbVie Inc

216.12

UNH

UnitedHealth Group Inc

388.17

AZN

AstraZeneca PLC

187.25

Live chat